Science Explorer Interactive view Map
Company · Bethesda · United States

Northwest Biotherapeutics (United States)

nwbio.comROR OpenAlex
Research works
52
▼ 72% vs 2013–17
Citations
2k
39.1 per fractional work
Top-10% rate
27.3%
record average 16.5%
Open access
17%
world 28%

Not ranked overall: Northwest Biotherapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Northwest Biotherapeutics (United States) specialise in?

Where its research is concentrated relative to its size: Life Sciences takes 3.4× the share of its output that it takes of world research.

  1. Life SciencesDomain · 26.6 works3.4×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Northwest Biotherapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Antigen Presentation, Innate Immunity, Dendritic Cells, Immunity, Immunotherapy, Tumor Microenvironment and Immune Checkpoint Blockade.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy16▲ 214×2 topics
  2. Antigen Presentation13▲ 254×2 topics
  3. Dendritic Cells12▲ 204×1 topic
  4. Immunity12▲ 70×1 topic
  5. Innate Immunity12▲ 68×2 topics
  6. Immunotherapy8▲ 23×7 topics
  7. Immune Checkpoint Blockade6▲ 188×1 topic
  8. PD-1 and PD-L16▲ 188×1 topic
  9. Tumor Microenvironment6▲ 30×2 topics
  10. Prostate Cancer5▲ 59×2 topics
  11. Tumor Regression4▲ 89×2 topics
  12. Gene Therapy4▲ 25×3 topics
  13. CAR T Cells3▲ 149×1 topic
  14. Chimeric Antigen Receptor3▲ 149×1 topic
  15. NK Cell Recognition3▲ 63×1 topic
  16. Natural Killer Cells3▲ 63×1 topic
  17. Biomarkers3▲ 9.7×2 topics
  18. Genetic Mutations3▲ 12×4 topics
  19. Androgen Receptor3▲ 63×1 topic
  20. Genomic Profiling3▲ 58×1 topic
  21. TGF-ß2▲ 28×2 topics
  22. Gene Silencing2▲ 36×2 topics
  23. RNA Interference2▲ 36×1 topic
  24. siRNA Delivery2▲ 53×1 topic
  25. CD4+CD25+2▲ 52×1 topic
  26. Foxp32▲ 52×1 topic
  27. Gleason Grading2▲ 74×1 topic
  28. Radiation Therapy2▲ 23×2 topics
  29. Screening2▲ 34×1 topic
  30. Angiogenesis1▲ 6.5×3 topics
  31. Monoclonal Antibodies1▲ 19×2 topics
  32. Glycosylation1▲ 11×3 topics
  33. Photodynamic Therapy1▲ 15×2 topics
  34. Fc Receptors1▲ 21×1 topic
  35. Host Defense1▲ 32×2 topics
  36. Therapeutic Antibodies1▲ 17×1 topic
  37. Biospectroscopic Study1▲ 250×1 topic
  38. Cancer Cells1▲ 250×1 topic
  39. Cancer Metastasis1▲ 61×1 topic
  40. Chemokine Receptors1▲ 121×1 topic

Which research topics does Northwest Biotherapeutics (United States) publish most on?

By volume in 2022–2025: Protein Degradation and Inhibitors, Hematopoietic Stem Cell Transplantation, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Protein Degradation and …0Protein Degradation and Inhibitors: 0 fractional worksHematopoietic Stem Cell …0Hematopoietic Stem Cell Transplantation: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksCytomegalovirus and herp…0Cytomegalovirus and herpesvirus research: 0 fractional worksAdvanced Proteomics Tech…0Advanced Proteomics Techniques and Applications: 0 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksImmunodeficiency and Aut…0Immunodeficiency and Autoimmune Disorders: 0 fractional works
Molecular BiologyHematologyOncologyImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 0 works
  2. 2 Hematopoietic Stem Cell Transplantation Hematology 0 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Cytomegalovirus and herpesvirus research Epidemiology 0 works
  7. 7 Advanced Proteomics Techniques and Applications Spectroscopy 0 works
  8. 8 Peptidase Inhibition and Analysis Oncology 0 works
  9. 9 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  10. 10 Glioma Diagnosis and Treatment Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.0%not open83.0%

World: 28% of research is openly available.

with international co-authors5.4%domestic only94.6%

World: 19% is written across borders.

How has Northwest Biotherapeutics (United States)'s research output changed?

Output in 2018–2022 was 72% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bethesda

All research institutions in Bethesda

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.